| Literature DB >> 24991437 |
Kirsi Väyrynen1, Kati Kortelainen2, Heikki Numminen2, Katja Miettinen3, Anna Keso3, Mirja Tenhunen4, Heini Huhtala5, Sari-Leena Himanen6.
Abstract
In acute stroke, OSA has been found to impair rehabilitation and increase mortality but the effect of central apnea is more unclear. The aim of the present study was to evaluate the feasibility of using limited ambulatory recording system (sleep mattress to evaluate nocturnal breathing and EOG-electrodes for sleep staging) in sleep disordered breathing (SDB) diagnostics in mild acute cerebral ischemia patients and to discover the prevalence of various SDB-patterns among these patients. 42 patients with mild ischemic stroke or transient ischemic attack were studied. OSA was found in 22 patients (52.4%). Central apnea was found in two patients (4.8%) and sustained partial obstruction in only one patient (2.4%). Sleep staging with EOG-electrodes only yielded a similar outcome as scoring with standard rules. OSA was found to be common even after mild stroke. Its early diagnosis and treatment would be favourable in order to improve recovery and reduce mortality. Our results suggest that OSA can be assessed by a limited recording setting with EOG-electrodes, sleep mattress, and pulse oximetry.Entities:
Year: 2014 PMID: 24991437 PMCID: PMC4058514 DOI: 10.1155/2014/317615
Source DB: PubMed Journal: Sleep Disord ISSN: 2090-3553
Sleep stage parameters of the PSG group with the two different scoring systems.
| Standard scoring | EOG scoring |
| |
|---|---|---|---|
| Median (min–max) | Median (min–max) | ||
| TST (min) | 321 (48.5–506.5) | 353.5 (49.5–498.5) | 0.051 |
| SEI (%) | 72.2 (42–90.9) | 69.1 (42.9–89.4) | 0.48 |
| % N1 | 12.8 (6.5–41.2) | 15.4 (6.8–48.5) | 0.068 |
| % N2 | 69.5 (36.1–83.2) | 66.2 (37.4–82.4) | 0.33 |
| % N3 | 7.0 (0–23.6) | 5.9 (0–17.7) | 0.17 |
| % REM | 11.2 (0–22.3) | 12.9 (0–25.4) | 0.61 |
Standard scoring: sleep stage scoring according to the standard rules; EOG scoring: sleep stage scoring based on the two EOG (electrooculography) channels only; TST: total sleep time; SEI: sleep efficiency index referred to analysis time; % N1–N3: percentage of N1–N3 sleep referred to TST; % REM: percentage of REM sleep referred to TST. Statistical comparisons with the Wilcoxon test.
Figure 1Example of the hypnograms of the same patient derived by the two different sleep staging procedures. The upper hypnogram represents standard sleep staging and the lower hypnogram represents EOG scoring. The hypnograms resemble each other but there are differences in both sleep efficiency (69% by standard sleep staging, 59% by EOG-scoring) and the arrangement of the sleep stages. The patient had moderate OSA (AHI 18.8/h).
The sleep quality parameters of the 42 patients.
| Median | Min | Max | |
|---|---|---|---|
| TST (min) | 368.5 | 48.5 | 510.5 |
| SEI (%) | 70.8 | 27.5 | 97.6 |
| % N1 | 8.8 | 1.8 | 41.2 |
| % N2 | 46.9 | 3.3 | 83.2 |
| % N3 | 6.5 | 0 | 26.2 |
| % REM | 7.1 | 0 | 31.2 |
TST: total sleep time; SEI: Sleep Efficiency Index referred to analysis time; % N1–N3: percentage of N1–N3 sleep referred to TST; % REM: percentage of REM sleep referred to TST.
The respiratory parameters of the PSG group and the POL group.
| PSG group | POL group | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Min | Max | Median | Min | Max | ||||
| AHI obstructive ( | 18.1 | 1.2 | 67.9 | ||||||
| AHI central ( | 0 | 0 | 1.2 | ||||||
| ODI4 | 4.5 | 0 | 32.5 | 6.0 | 0 | 64.8 | |||
| % OP1–OP3 | 27.2 | 2.6 | 69.3 | 14.1 | 0 | 45.8 | |||
| % CP | 0 | 0 | 4.7 | 0 | 0 | 51.6 | |||
| % IRR | 0.8 | 0 | 9.6 | 0.5 | 0 | 25.4 | |||
| SaO2min (%) | 87.5 | 79.0 | 93.0 | 85.0 | 75.0 | 91.0 | |||
| SaO2mean (%) | 93.7 | 90.7 | 96.5 | 93.2 | 89.5 | 97.1 | |||
| Pulse (bpm) | 55 | 46 | 73 | 58 | 46 | 86 | |||
AHI obstructive: number of obstructive apneas and hypopneas per hour of sleep; AHI central: number of central apneas per hour of sleep; ODI4: number of desaturations per hour of sleep; % OP1–OP3: percentage of time with obstructive periodic breathing as detected by Emfit sensor; % CP: percentage of time with central periodic breathing as detected by Emfit sensor; % IRR: percentage of time with prolonged partial obstruction as detected by Emfit sensor; SaO2min: minimum oxygen saturation percentage; SaO2mean: average oxygen saturation percentage; Pulse: mean pulse per minute.
Some demographic and sleep parameters of the different subject groups.
| Non-SDB, | OSA, | Central, | IRR, | Non-SDB versus OSA | |
|---|---|---|---|---|---|
| Median (min–max) | Median (min–max) | Median (min–max) | Value |
| |
| BMI | 26.0 (19.9–32.7) | 26.6 (21.9–37.4) | 25.3 (25.2–25.3) | 27.5 | 0.705 |
| AGE | 62 (45–79) | 69 (37–82) | 77 (75–78) | 68 | 0.131 |
| TST | 426 (49–511) | 321 (105–490) | 300 (282–318) | 416 | 0.116 |
| SEI | 72.8 (42.0–97.6) | 70.3 (27.5–95.7) | 65.2 (61.3–69.1) | 67.2 | 0.236 |
| % N1 | 8.9 (2.6–41.2) | 9.0 (1.8–23.0) | 12.5 (11.9–13.1) | 8.2 | 0.962 |
| % N2 | 45.9 (33.1–73.9) | 57.8 (3.3–83.2) | 44.7 (42.7–46.7) | 53.6 | 0.168 |
| % N3 | 12.4 (3.3–26.2) | 4.3 (0–23.6) | 1.5 (1.1–1.8) | 2.4 | 0.005 |
| % REM | 6.9 (0–22.3) | 10.8 (1.0–31.2) | 6.9 (5.2–8.5) | 3.1 | 0.539 |
| ODI4 | 1.8 (0–8.2) | 16.4 (0–64.8) | 9.7 (4.2–15.1) | 0.7 | 0.000 |
| SaO2min (%) | 87 (80–91) | 85 (75–93) | 87 (84–89) | 85 | 0.053 |
| SaO2mean (%) | 93.6 (90.7–97.1) | 93.3 (89.5–96.8) | 94.5 (93.3–95.7) | 91.7 | 0.975 |
| Pulse (bpm) | 61 (50–86) | 58 (46–78) | 51 (50–52) | 51 | 0.133 |
| NIHSS | 2 (0–6) | 1 (0–4) | 3 (2–4) | 1 | 0.138 |
| Neck (cm) | 40 (34–44) | 41 (38–53) | 41 (40–42) | 39 | 0.231 |
NIHSS: National Institutes of Health Stroke Scale; Neck: neck circumference in centimeters.
The rest of the abbreviations are as in Tables 1 and 3. Statistical comparisons between the Non-SDB group and the OSA group with the Mann-Whitney test.
Demographic parameters of the 42 patients.
| Non-SDB | OSA | Central | IRR | |
|---|---|---|---|---|
| Depression (%) | 5.9 | 4.5 | 0 | 0 |
| Previous stroke (%) | 5.9 | 13.6 | 0 | 0 |
| Heart failure (%) | 23.5 | 27.3 | 0 | 0 |
| Hypertension (%) | 47.1 | 63.6 | 50 | 100 |
| Hypercholesterolemia (%) | 11.8 | 13.6 | 0 | 0 |
| Diabetes mellitus (%) | 5.9 | 4.5 | 0 | 0 |
| Hypothyreosis (%) | 5.9 | 4.5 | 0 | 100 |
| Asthma (%) | 5.9 | 0 | 0 | 0 |
| COPD (%) | 17.6 | 4.5 | 0 | 0 |
| Tobacco use (%) | 47 | 18.1 | 50 | 0 |
| Alcohol use (%) | 29.4 | 22.7 | 0 | 0 |
| Snoring (%) | 52.9 | 54.5 | 50 | 100 |
| Witnessed apneas (%) | 5.9 | 22.7 | 50 | 0 |
| Increased sleepiness | 76.5 | 40.9 | 0 | 100 |
COPD: chronic obstructive pulmonal disease.